Dr Albert Lim

Dr Albert Lim is a Consultant Paediatric Neurologist and expert witness who has held a substantive NHS consultant position at the Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, since July 2023. His principal clinical expertise includes traumatic and acquired brain injury, complex epilepsy, cerebral palsy, severe neurodisability, spasticity management, paediatric neurogenetics and rare neurological disorders.
His tertiary clinical practice encompasses children from the neonatal period through adolescence, including those with complex neurological conditions requiring specialist assessment and ongoing management. He has particular experience managing drug-resistant epilepsy, including treatment with multiple antiseizure medications, vagus nerve stimulation and ketogenic dietary therapy.

Dr Lim is the regional lead for the Intrathecal Baclofen Pump Service, overseeing specialist treatment for children and young people with severe cerebral palsy, spasticity and profound neurodisability. He also practises within the NHS Highly Specialised Service for Rare Mitochondrial Disorders, contributing expertise in complex neurogenetic, metabolic and progressive neurological conditions.

Alongside his clinical responsibilities, Dr Lim holds a PhD in Clinical Neuroscience and has undertaken extensive research into neurological disease progression, clinical outcomes and emerging treatments for rare neurological disorders. His academic work complements his specialist clinical practice and contributes to his understanding of complex paediatric neurological conditions.

Dr Albert Lim has undertaken medico-legal work since 2019, providing independent expert opinion in clinical negligence, personal injury, Court of Protection and family proceedings. He accepts instructions on behalf of both claimants and defendants, with a focus on complex paediatric neurological cases involving children and young people.

His medico-legal expertise encompasses traumatic and acquired brain injury, complex epilepsy, cerebral palsy, hypoxic-ischaemic encephalopathy, severe neurodisability and rare neurological disorders. He provides expert reports addressing breach of duty, causation, condition and prognosis, including the neurological consequences of injury or disease and their implications for long-term outcomes.

Dr Lim's medico-legal assessments consider neurological impairment, disease progression and future needs, including rehabilitation, therapy, specialist equipment, education and multidisciplinary support. His expertise enables him to address complex questions concerning neurological causation and prognosis in paediatric claims.

Dr Albert Lim's clinical interests centre on the assessment and management of complex neurological conditions in children and young people, particularly where neurological impairment has significant implications for development, function and long-term care.

A key area of his practice involves the management of difficult-to-treat epilepsy, including post-traumatic epilepsy and seizures associated with underlying genetic or metabolic disorders. His work includes assessing treatment response and managing children who require specialist interventions for persistent seizures.

He also has a particular interest in severe motor impairment and spasticity associated with cerebral palsy and other neurological conditions. His clinical work involves assessing the impact of these conditions on mobility, function and daily activities, alongside the management of children requiring intrathecal baclofen treatment.

Further specialist interests include neonatal encephalopathy, hypoxic-ischaemic brain injury and progressive neurological disorders. His practice encompasses the assessment of neurological outcomes, disease progression and longer-term support requirements, including rehabilitation, therapy, specialist equipment and multidisciplinary care for children with complex neurological needs.

Dr Albert Lim holds a PhD in Clinical Neuroscience and has undertaken NIHR and Wellcome-supported academic fellowships. His research focuses on neurological disease progression, genotype-phenotype relationships and clinical outcomes in rare neurological disorders. He has published in leading peer-reviewed journals, including Annals of Neurology, European Journal of Paediatric Neurology and Brain Communications. His academic achievements include the Yogi Memorial Prize (2023) and the John Hanson Award for Patient Safety (2022).